Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53.9M |
| 2 |
COUP
Coupa Software Incorporated
COUP
|
+$32.1M |
| 3 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$27.8M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$20.1M |
| 5 |
M&T Bank
MTB
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Y
Alleghany Corp
Y
|
+$93.4M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$71.8M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.9M |
| 4 |
ZEN
ZENDESK INC
ZEN
|
+$42.3M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$41.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.01% |
| 2 | Financials | 11.75% |
| 3 | Industrials | 10.85% |
| 4 | Healthcare | 10.32% |
| 5 | Consumer Discretionary | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Factset
FDS
$10.7B
| $8.15M | 0.16% |
20,303
+12,167
| +150% | +$5.18M |
|
127
Entegris
ENTG
$22B
| $8.13M | 0.16% |
+123,921
| New | +$9.13M |
|
128
Eastman Chemical
EMN
$8.47B
| $8.06M | 0.16% |
98,985
+20,852
| +27% | +$1.68M |
|
129
Humana
HUM
$45.5B
| $8.04M | 0.16% |
+15,688
| New | +$8.25M |
|
130
Zscaler
ZS
$29.4B
| $8.02M | 0.16% |
+71,645
| New | +$9.73M |
|
|
EA
131
DELISTED
Electronic Arts
EA
| $7.97M | 0.16% |
+65,206
| New | +$8.19M |
|
132
First Financial Bankshares
FFIN
$4.89B
| $7.87M | 0.16% |
228,782
+100,848
| +79% | +$3.82M |
|
133
Trade Desk
TTD
$6.19B
| $7.84M | 0.16% |
+174,834
| New | +$8.86M |
|
134
Brunswick
BC
$5.24B
| $7.84M | 0.16% |
108,729
+68,898
| +173% | +$4.9M |
|
135
Silicon Laboratories
SLAB
$7.27B
| $7.77M | 0.15% |
+57,267
| New | +$7.53M |
|
136
SentinelOne
S
$7.26B
| $7.76M | 0.15% |
531,971
+282,019
| +113% | +$5.22M |
|
137
Reinsurance Group of America
RGA
$15.9B
| $7.73M | 0.15% |
+54,422
| New | +$7.6M |
|
138
Estee Lauder
EL
$36.9B
| $7.71M | 0.15% |
31,074
+27,072
| +676% | +$6.05M |
|
139
Hilton Grand Vacations
HGV
$3.51B
| $7.68M | 0.15% |
199,276
+107,578
| +117% | +$4.25M |
|
140
TransDigm Group
TDG
$66.4B
| $7.64M | 0.15% |
12,132
-9,698
| -44% | -$5.71M |
|
|
TXNM
141
TXNM Energy Inc
TXNM
$5.9B
| $7.62M | 0.15% |
156,118
+28,147
| +22% | +$1.34M |
|
142
Warner Bros
WBD
$71.6B
| $7.6M | 0.15% |
801,504
-179,787
| -18% | -$2.03M |
|
|
TGNA
143
DELISTED
TEGNA Inc
TGNA
| $7.55M | 0.15% |
356,161
+326,293
| +1,092% | +$6.58M |
|
144
3M
MMM
$92.3B
| $7.52M | 0.15% |
+75,020
| New | +$7.65M |
|
145
PUT
JPMorgan Chase
JPM
$935B
| $7.51M | 0.15% |
56,000
+1,300
| +2% | +$165K |
|
146
H&R Block
HRB
$6.62B
| $7.5M | 0.15% |
205,521
+55,943
| +37% | +$2.27M |
|
147
Qiagen
QGEN
$9.1B
| $7.45M | 0.15% |
140,867
+85,004
| +152% | +$4.19M |
|
148
IQVIA
IQV
$42.8B
| $7.44M | 0.15% |
36,315
-50,384
| -58% | -$10.2M |
|
149
Omega Healthcare
OHI
$14.1B
| $7.43M | 0.15% |
265,727
+245,593
| +1,220% | +$7.41M |
|
150
Freeport-McMoran
FCX
$110B
| $7.42M | 0.15% |
195,303
+165,303
| +551% | +$5.78M |
|
Similar funds
Paul Tudor Jones's Q4 2022 Portfolio in Review
As of Q4 2022, Paul Tudor Jones held 3,056 positions worth $5.06B, up 9.2% from $4.63B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Paul Tudor Jones deployed $198M of net new capital in Q4 2022, opening 801 new positions and adding to 766 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $39M trimmed.
- Paul Tudor Jones's largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 648,672 shares worth $73.8M.
- Paul Tudor Jones added most to Coupa Software Incorporated in Q4 2022, an estimated $32.1M increase.
- Paul Tudor Jones's biggest Q4 2022 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $39M.
- Paul Tudor Jones fully exited Alleghany Corp in Q4 2022, selling an estimated $93.4M.
- Paul Tudor Jones's ten largest holdings make up 9.1% of its $5.06B portfolio in Q4 2022.
- Paul Tudor Jones opened 801 new positions and closed 756 in Q4 2022.
- Paul Tudor Jones's portfolio value rose 9.2% quarter-over-quarter to $5.06B.
Based on Tudor Investment Corp's 13F filing for Q4 2022, filed 14 Feb 2023.